Canada markets closed

Societal CDMO, Inc. (SCTL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7950+0.0351 (+4.62%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.7599
Open0.7447
Bid0.0000 x 1400
Ask0.0000 x 1800
Day's Range0.7324 - 0.7964
52 Week Range0.6200 - 2.6660
Volume81,495
Avg. Volume144,263
Market Cap45.023M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-0.2600
Earnings DateAug 08, 2022 - Aug 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.50
  • GlobeNewswire

    Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish and Lyophilization Unit at San Diego Facility

    Japanese Biopharmaceutical Company Engages Societal for Formulation, Fill/Finish and Lyophilization Activities to Support Ongoing Clinical Development of Novel Cancer TherapeuticSAN DIEGO and GAINESVILLE, Ga., June 08, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced a key

  • GlobeNewswire

    Societal CDMO Selected By AmyriAD Pharma to Provide Clinical Trials Services to Support Pivotal Phase 3 Program For Alzheimer’s Disease Treatment, AD101

    Activities Planned at Both Georgia and California Facilities, Highlighting Benefits of Societal’s Bi-Coastal FootprintSAN DIEGO and GAINESVILLE, Ga., June 01, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it has been selected by AmyriAD Pharma to provide CDMO servi

  • GlobeNewswire

    Societal to Participate in Upcoming Investor Conferences

    SAN DIEGO and GAINESVILLE, Ga., May 19, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will participate in three upcoming investor conferences. Details of the company’s participation are as follows: H.C. Wainwright Global Investment Confere